Lewes, DE -- (SBWIRE) -- 09/07/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: American Realty Capital Properties Inc (NASDAQ:ARCP), Akorn, Inc. (NASDAQ:AKRX), Affymetrix, Inc. (NASDAQ:AFFX), Sequenom, Inc. (NASDAQ:SQNM).
American Realty Capital Properties Inc (NASDAQ:ARCP) increased 0.63% and closed at $12.75 on a traded volume of 1.77million shares, in comparison to 2.88 million shares of average trading volume. So far this year, the stock is down over -3.99%.
The company has a total market capitalization of $2.36 billion and its total outstanding shares are 184.89 million.
Will ARCP Continue To Move Higher? Find Out Here
American Realty Capital Properties, Inc. owns and acquires single tenant, freestanding commercial real estate that is net leased on a medium-term basis, primarily to investment grade credit rated and other creditworthy tenants.
Akorn, Inc. (NASDAQ:AKRX) soared 40.16% and closed at $18.95 on a traded volume of 1.74 million shares, whereas its average trading volume is 754.389 shares. In the last three months, the stock is up 40.16%. The Intra-day range for the stock is $18.52 and $19.37.
Will AKRX Continue To Move Higher? Find Out Here
Akorn, Inc. engages in the manufacture and marketing of diagnostic and therapeutic ophthalmic pharmaceuticals products, hospital drugs, and inject able pharmaceuticals in the United States and internationally.
Affymetrix, Inc. (NASDAQ:AFFX) dropped -0.99% and closed at $5.98. So far in three months, the stock is up 63.84%. The 52-week range for the stock is $2.96 and $6.51 and during the previous trading session the stock touched its highest price at $6.26. Its introductory price for the day was $6.10, with the overall traded volume of 1.73 million shares.
Will AFFX Get Buyers Even After The Recent Rally? Find Out Here
Affymetrix, Inc. provides life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein, and cell level primarily in the United States, Europe, Latin America, and Asia.
Sequenom, Inc. (NASDAQ:SQNM) after opening its trade at the price of $3.01, dropped -1.67% to close at $2.95 for the day. The stock moved on a traded volume of 1.72 million shares, in comparison to 4.38 million shares of average trading volume.
The 52-week range for the stock is $2.75 and $5.36 and during the previous trading session the stock touched its highest price at $3.03.
Will SQNM Get Buyers Even After The Recent Rally? Find Out Here
Sequenom, Inc., a life sciences company, provides genetic analysis solutions in the United States and internationally. It operates through two segments, Molecular Diagnostics and Genetic Analysis.
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/